(Q33879436)

29 July 2017

1 reference

title

Inhibition of transcription factors by anti-inflammatory and anti-rheumatic drugs: can variability in response be overcome? (English)

1 reference

29 July 2017

Handel ML

1 reference

29 July 2017

Nguyen LQ

series ordinal

1 reference

29 July 2017

Lehmann TP

series ordinal

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Clinical and Experimental Pharmacology and Physiology

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

139-144

1 reference

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Transcription factors AP-1 and NF-kappa B: where steroids meet the gold standard of anti-rheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Role of NFkappaB in the mortality of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Inhibition of activator protein 1 activity and neoplastic transformation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Nuclear protein CBP is a coactivator for the transcription factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Activation of cAMP and mitogen responsive genes relies on a common nuclear factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03216.X

10.1046/J.1440-1681.2000.03216.X

21 January 2018

Identifiers

DOI

1 reference

release_5zy25mc7wrc63d3fq7m5cgc6li

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5zy25mc7wrc63d3fq7m5cgc6li

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference